(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Justin Gover, CEO of GW Pharmaceuticals, on the drug pipeline for the UK- based company which has been developing drug treatments derived from cannabis for decades.

Meta to Spend Up to $27 Billion on Nebius AI Infrastructure
15:55

Adobe CEO to Step Down in Face of Investor Concerns Over AI
18:19

Dick’s Projects Sales Growth at Namesake Stores, Foot Locker
14:01